GEMPHIRE THERAPEUTICS

Gemphire Therapeutics manufactures and markets Gemcabene, an LDL cholesterol-lowering medication. It is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH. The company was founded in 2014 and is based in Northville, Michigan.

#SimilarOrganizations #People #Financial #Website #More

GEMPHIRE THERAPEUTICS

Industry:

Biotechnology Manufacturing Therapeutics

Founded:

2014-01-01

Address:

Northville, Michigan, United States

Country:

United States

Website Url:

http://www.gemphire.com

Total Employee:

11+

Status:

Closed

Contact:

(248) 980-6538

Total Funding:

18.4 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 Google Maps Microsoft Azure DNS GoDaddy DNS Google Maps API DigiCert SSL

Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

werewolf-therapeutics-logo

Werewolf Therapeutics

Werewolf Therapeutics operates as an oncology biotherapeutics company.

Current Advisors List

p-kent-hawryluk_image

P. Kent Hawryluk Board Member @ Gemphire Therapeutics
Board_member
2015-02-01

Founder

charles-bisgaier_image

Charles Bisgaier

Investors List

cb-health-ventures_image

Official Site Inspections

http://www.gemphire.com

Host Informations
Whois Informations

Loading ...